Literature DB >> 31917535

Sequence Multiplicity within Spherical Nucleic Acids.

Ziyin N Huang, Lisa E Cole, Cassandra E Callmann, Shuya Wang, Chad A Mirkin.   

Abstract

The synthesis and evaluation of spherical nucleic acids (SNAs) incorporating two physically and chemically distinct classes of oligonucleotides (ODNs) at programmed ratios are described. These SNAs are single entity agents that enter the same target cell at defined stoichiometries, and as such allow one to control important cell signaling and regulatory processes. To study the effect of sequence multiplicity within such structures, we synthesized SNAs consisting of a mixture of class A CpG and class B CpG, immunostimulatory ODNs that activate two different toll-like receptor 9 signaling pathways, each in a sequence-specific fashion. These dual-CpG SNAs exhibit high cellular uptake and codelivery of the two ODNs, relative to mixtures of the linear ODN counterparts, and remain highly associated inside the cell over time. Furthermore, the dual-CpG SNAs augment dendritic cell maturation, compared to the same amounts of oligonucleotides delivered in linear or SNA form but not conjugated to one another. Consequently, these structures constitute a platform for designing oligonucleotide-based combination therapeutics with highly tailorable activities.

Entities:  

Keywords:  DNA nanotechnology; biotechnology; immunotherapy; microscopy; spherical nucleic acids

Mesh:

Substances:

Year:  2020        PMID: 31917535      PMCID: PMC7027983          DOI: 10.1021/acsnano.9b08750

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  33 in total

1.  Multiplexed nanoflares: mRNA detection in live cells.

Authors:  Andrew E Prigodich; Pratik S Randeria; William E Briley; Nathaniel J Kim; Weston L Daniel; David A Giljohann; Chad A Mirkin
Journal:  Anal Chem       Date:  2012-01-30       Impact factor: 6.986

2.  Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.

Authors:  Alexandre de Titta; Marie Ballester; Ziad Julier; Chiara Nembrini; Laura Jeanbart; André J van der Vlies; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

3.  The physiological regulation of toll-like receptor expression and function in humans.

Authors:  Graeme I Lancaster; Qamar Khan; Pam Drysdale; Fiona Wallace; Asker E Jeukendrup; Mark T Drayson; Michael Gleeson
Journal:  J Physiol       Date:  2005-01-20       Impact factor: 5.182

Review 4.  Nucleic acid-sensing TLRs: trafficking and regulation.

Authors:  Olivia Majer; Bo Liu; Gregory M Barton
Journal:  Curr Opin Immunol       Date:  2016-11-28       Impact factor: 7.486

Review 5.  Therapeutic potential of Toll-like receptor 9 activation.

Authors:  Arthur M Krieg
Journal:  Nat Rev Drug Discov       Date:  2006-06       Impact factor: 84.694

6.  Dual Toll-Like Receptor Targeting Liposomal Spherical Nucleic Acids.

Authors:  Jennifer R Ferrer; Jason A Wertheim; Chad A Mirkin
Journal:  Bioconjug Chem       Date:  2019-03-04       Impact factor: 4.774

7.  Asymmetric functionalization of gold nanoparticles with oligonucleotides.

Authors:  Xiaoyang Xu; Nathaniel L Rosi; Yuhuang Wang; Fengwei Huo; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2006-07-26       Impact factor: 15.419

8.  Rational vaccinology with spherical nucleic acids.

Authors:  Shuya Wang; Lei Qin; Gokay Yamankurt; Kacper Skakuj; Ziyin Huang; Peng-Cheng Chen; Donye Dominguez; Andrew Lee; Bin Zhang; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-08       Impact factor: 11.205

9.  RNA-Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators.

Authors:  Chenxia Guan; Natalia Chernyak; Donye Dominguez; Lisa Cole; Bin Zhang; Chad A Mirkin
Journal:  Small       Date:  2018-10-29       Impact factor: 13.281

10.  The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

Authors:  Carlee E Ashley; Eric C Carnes; Genevieve K Phillips; David Padilla; Paul N Durfee; Page A Brown; Tracey N Hanna; Juewen Liu; Brandy Phillips; Mark B Carter; Nick J Carroll; Xingmao Jiang; Darren R Dunphy; Cheryl L Willman; Dimiter N Petsev; Deborah G Evans; Atul N Parikh; Bryce Chackerian; Walker Wharton; David S Peabody; C Jeffrey Brinker
Journal:  Nat Mater       Date:  2011-04-17       Impact factor: 43.841

View more
  6 in total

1.  Tumor cell lysate-loaded immunostimulatory spherical nucleic acids as therapeutics for triple-negative breast cancer.

Authors:  Cassandra E Callmann; Lisa E Cole; Caroline D Kusmierz; Ziyin Huang; Dai Horiuchi; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

Review 2.  Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy.

Authors:  Ziyin Huang; Cassandra E Callmann; Shuya Wang; Matthew K Vasher; Michael Evangelopoulos; Sarah Hurst Petrosko; Chad A Mirkin
Journal:  ACS Cent Sci       Date:  2022-05-20       Impact factor: 18.728

3.  Tracking endocytosis and intracellular distribution of spherical nucleic acids with correlative single-cell imaging.

Authors:  Mengmeng Liu; Fei Wang; Xueli Zhang; Xiuhai Mao; Lihua Wang; Yang Tian; Chunhai Fan; Qian Li
Journal:  Nat Protoc       Date:  2020-12-07       Impact factor: 13.491

Review 4.  Spherical Nucleic Acids as Precision Therapeutics for the Treatment of Cancer-From Bench to Bedside.

Authors:  Akanksha S Mahajan; Alexander H Stegh
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

5.  Impact of Liposomal Spherical Nucleic Acid Structure on Immunotherapeutic Function.

Authors:  Cassandra E Callmann; Caroline D Kusmierz; Jasper W Dittmar; Leah Broger; Chad A Mirkin
Journal:  ACS Cent Sci       Date:  2021-04-15       Impact factor: 14.553

6.  Synergistic Immunostimulation through the Dual Activation of Toll-like Receptor 3/9 with Spherical Nucleic Acids.

Authors:  Ziyin N Huang; Cassandra E Callmann; Lisa E Cole; Shuya Wang; Chad A Mirkin
Journal:  ACS Nano       Date:  2021-07-19       Impact factor: 15.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.